Industry Notes:
Using Breathalyzers to Diagnose COVID-19
Published on Mon May 02, 2022
On April 14, 2022, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for a diagnostic test that can detect compounds associated with COVID-19 in breath samples. The InspectIR COVID-19 Breathalyzer showed to have 91.2 percent sensitivity (percentage of correctly identified positive samples) and 99.3 percent specificity (percentage of correctly identified negative samples) in a study [...]